Xenetic Biosciences, Inc.
Pharmaceutical company · Framingham, Massachusetts, United States · Nasdaq: XBIO
Xenetic Biosciences, Inc. is a pharmaceutical company headquartered in Framingham, Massachusetts, United States. Its shares trade on Nasdaq under the ticker XBIO. It has reported private securities offerings to the US SEC, most recently $488,835 sold in a notice filed in 2022.
Xenetic Biosciences at a glance
What does Xenetic Biosciences do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $488,835 sold (2022).
Frequently asked questions about Xenetic Biosciences
Where is Xenetic Biosciences headquartered?
Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts, United States.
What does Xenetic Biosciences do?
Xenetic Biosciences, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Xenetic Biosciences a public company?
Yes. Xenetic Biosciences, Inc. trades on Nasdaq under the ticker XBIO.
Similar companies
- Pulmatrix, Inc.Framingham, Massachusetts, United States
- Alzheon, Inc.Framingham, Massachusetts, United States
- KalVista Pharmaceuticals, Inc.Framingham, Massachusetts, United States
- LFB USA Inc.Framingham, Massachusetts, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences